Keyphrases
Acute Anterior Uveitis
33%
Ancillary
33%
Ankylosing Spondylitis
33%
Ankylosing Spondylitis Disease Activity Score (ASDAS)
33%
Axial Spondyloarthritis (AxSpA)
70%
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
30%
Biological Therapy
16%
C-reactive Protein
8%
Clinical Characteristics
5%
Colegio
11%
Confidence Interval
16%
Dactylitis
8%
Delphi Study
33%
Diagnostic Delay
22%
Disease Activity
16%
Disease-modifying Antirheumatic Drugs (DMARDs)
11%
Functional Limitations
11%
High Disease Activity
22%
HLA-B27
52%
Inhibitor Treatment
16%
Long-term Treatment
16%
Low Disease Activity
33%
Modified Stoke Ankylosing Spondylitis Spine Score
11%
Multidisciplinary Groups
11%
Multidisciplinary Unit
33%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
11%
Nonprogressors
11%
Odds Ratio
26%
Patient Association
11%
Patient Characteristics
5%
Patient Survey
11%
Peripheral Spondyloarthritis
33%
Pharmacological Treatment
11%
Points to Consider
33%
Progressors
11%
Psoriatic Arthritis
33%
Psychological Distress
22%
Radiographic Progression
16%
Rheumatologists
6%
Rheumatology
14%
Sociedad
11%
Spain
33%
Spondyloarthritis
16%
Stiffness
11%
Survey Data
11%
Systematic Literature Review
33%
TNF Inhibitors
33%
Undertreated
11%
University Studies
11%
Uveitis
38%
Medicine and Dentistry
Ankylosing Spondylitis
44%
Ankylosing Spondylitis Disease Activity Score
33%
Arthritis
8%
BASDAI
22%
Bath Ankylosing Spondylitis Functional Index
5%
Biological Therapy
16%
C Reactive Protein
8%
Dactylitis
8%
Dermatology
14%
Diagnostic Delay
22%
Disease Activity
58%
Disease-Modifying Antirheumatic Drug
11%
Diseases
26%
Distress Syndrome
22%
Drug Therapy
11%
Functional Limitation
11%
General Health Questionnaire
11%
HLA-B27
52%
Inflammatory Bowel Disease
5%
Iridocyclitis
33%
Multivariate Analysis
5%
Nonsteroid Antiinflammatory Agent
11%
Odds Ratio
26%
Psoriasis
5%
Psoriatic Arthritis
33%
Rheumatology
14%
Spondylarthritis
100%
Systematic Review
33%
TNF Inhibitor
33%
Uveitis
38%
Nursing and Health Professions
Ankylosing Spondylitis
11%
Ankylosing Spondylitis Disease Activity Score
33%
Bath Ankylosing Spondylitis Disease Activity Index
16%
Biological Therapy
16%
C Reactive Protein
5%
Diagnosis
22%
Disease
16%
Disease Activity
55%
Distress Syndrome
22%
Drug Therapy
11%
Erythrocyte Sedimentation Rate
5%
General Health Questionnaire
11%
Long Term Care
16%
Nonsteroid Antiinflammatory Agent
11%
Practice Guideline
9%
Psoriatic Arthritis
33%
Rigidity
11%
Spondylarthritis
66%
Systematic Review
33%
Tumor Necrosis Factor Inhibitor
33%
X Ray Film
5%
